Search

Your search keyword '"Leni R"' showing total 426 results

Search Constraints

Start Over You searched for: Author "Leni R" Remove constraint Author: "Leni R"
426 results on '"Leni R"'

Search Results

1. Prior degree and academic performance in medical school: evidence for prioritising health students and moving away from a bio-medical science-focused entry stream

2. Differential Level of RXFP3 Expression in Dopaminergic Neurons Within the Arcuate Nucleus, Dorsomedial Hypothalamus and Ventral Tegmental Area of RXFP3-Cre/tdTomato Mice

3. Paulo da Gama e os narradores em Os Lusíadas, de Luís de Camões

7. The impact of centralized uropathology review in the management of bladder cancer patients at the time of transurethral resection of the bladder

8. The impact of multiple lesions in prostate MRI – insights from the YAU prostate cancer group

9. PSA doubling time thresholds in predicting clinical recurrence after biochemical recurrence in surgically treated prostate cancer patients. The Impact of nodal status and adjuvant radiotherapy

10. Does the accuracy of PSA density change according to prostate volume? Assessing the diagnostic accuracy at the extreme values of prostate volume in a large single institution series

11. The quantification of GSP4 volume is superior to ISUP GG classification and %GSP4 for predicting adverse outcomes in radical prostatectomy patients

13. Optimizing detection and prediction of prostate cancer after positive MRI and negative biopsies

14. Age-dependent effect of early salvage radiotherapy for biochemical recurrence in prostate cancer patients treated with radical prostatectomy

15. PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection: Updated results of a planned interim analysis of a prospective phase 2 study

17. Cancer control rates in adequate versus inadequate treatment with adjuvant immunotherapy instillations with BCG

18. Long-term oncological outcomes of surgically managed very high-risk prostate cancer patients according to the STAMPEDE trial definition: Implications for the selection of candidates for clinical trials

19. Do incidental prostate cancer patients managed with active surveillance exhibit different disease features and outcomes compared to their biopsy-diagnosed counterparts? Results of a multi-institutional study

20. A novel PRECISE implemented predictive model to assess the risk of long-term disease reclassification in men on active surveillance. Results from a large, single institution series

21. Clinical characteristics and oncologic outcomes of bladder neuroendocrine carcinoma in a contemporary, multi-institutional cohort

22. The role of artificial intelligence for the detection of clinically significant prostate cancer at multiparametric magnetic resonance imaging

23. Optimizing the number of systematic cores during MRI target biopsy. Preliminary results from the prospective, paired-cohort SCOT Trial

24. The importance of high volume providers in the diagnostic pathways of prostate cancer. Results from large, singe Institution series

25. Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series

26. How can we reduce the rates of false positive findings at mpMRI? The pivotal role of urologist expertise assessed in a large, single center series

27. Yoyo Dieting, Post-Obesity Weight Loss, and Their Relationship with Gut Health.

28. The Impact of Yoyo Dieting and Resistant Starch on Weight Loss and Gut Microbiome in C57Bl/6 Mice.

31. Oncologic outcomes of patients with incidental prostate cancer: Can we rely on multiparametric mri to exclude aggressive prostate cancer?

32. Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients?

33. Impact of neoadjuvant immune-checkpoint inhibitor on intra and post operative outcomes in patients with muscle-invasive bladder cancer treated with radical cystectomy

34. Can we predict the site of positive surgical margins based on the site of the index lesion at multiparametric mri? A topographic, single center study

37. 99M-technetium-psma radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection: a phase 2 prospective, single-institution study

38. The risk of recurrence in cN1 prostate cancer patients treated with radical prostatectomy varies according to the type preoperative staging. a comparison between 68ga-PSMA-PET versus conventional imaging in a large, multi-institutional study

39. Oncologic surveillance for variant histology upper tract urothelial carcinoma

40. Are extended pelvic lymph node dissection-related complications still an issue in contemporary patients treated with robot-assisted radical prostatectomy? a prospective assessment using a standardized collection system

41. The impact of variant histology on the probability of lymph node involvement at imaging: CT scan vs FDG PET

42. Reliability of 68Ga-PSMA PET/CT in assessing real nodal burden in men with cN1 disease: clinical implications for patient counselling and multi-modal treatments

43. Optimizing timing and indications for 68Ga-PSMA PET/CT in patients with biochemical recurrent prostate cancer after radical prostatectomy

44. The role of FDG PET in the staging of bladder cancer patients candidate for radical cystectomy

45. Implementing the follow-up schedule after radical nephrouretrectomy for low risk upper tract urothelial carcinoma

46. The impact of frailty status on surgical outcomes after robot-assisted radical prostatectomy - a prospective assessment using a standardized collection system for perioperative outcomes

47. Increased awareness of surgical outcomes improves long-term functional outcomes after robot-assisted radical prostatectomy. A prospective assessment following implementation of prospective data collection

48. Does centralized revision of prostate biopsy impact on active surveillance outcomes? results from a single, high-volume institution series

49. The impact of histological variants on the performance characteristics of 68Ga-PSMA PET/CT in the primary and recurrent setting

50. Drop-out rates from active surveillance for disease progression remain consistent and not negligible over time. A plea for long-term assessment based on a large, prospectively collected active surveillance cohort

Catalog

Books, media, physical & digital resources